{
    "eid": "2-s2.0-85127429024",
    "title": "Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Alpha-mangostin",
        "Motor deficits",
        "Nanoencapsulated lipid carriers",
        "Parkinson\u2019s disease",
        "Substantia nigra"
    ],
    "authors": [
        "Romgase Sakamula",
        "Teerapong Yata",
        "Wachiryah Thong-asa"
    ],
    "citedby-count": 4,
    "ref-count": 54,
    "ref-list": [
        "Rotenone-induced nigrostriatal toxicity is reduced by methylene blue",
        "Lipid peroxidation inhibition and antiradical activities of some leaf fractions of Mangifera indica",
        "Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease",
        "Parkinson's Disease and the Environment",
        "Nanostructured lipid carriers: Promising drug delivery systems for future clinics",
        "Protective effect of \u03b1-mangostin on cardiac reperfusion damage by attenuation of oxidative stress",
        "A highly reproducible rotenone model of Parkinson's disease",
        "Parkinson's disease: mechanisms and models",
        "Parkinsons Disease and Its Management Part 1 Disease Entity Risk Factors Pathophysiology",
        "Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles",
        "Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study",
        "Tissue sulfhydryl groups",
        "Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting",
        "Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death",
        "Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra",
        "A phenotypic model recapitulating the neuropathology of Parkinson's disease",
        "Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone",
        "Data supporting the spectrophotometric method for the estimation of catalase activity",
        "Neuroprotective effect of \u03b1-mangostin on mitochondrial dysfunction and \u03b1-synuclein aggregation in rotenone-induced model of Parkinson\u2019s disease in differentiated SH-SY5Y cells",
        "Application of nanostructured lipid carriers: The prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway",
        "Nanostructured Lipid Carriers Made of \u03a9-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases",
        "Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats",
        "\u03b1-Mangostin from Garcinia mangostana Linn: An updated review of its pharmacological properties",
        "Neuroprotective Effects of Alpha-Mangostin on MPP+-Induced Apoptotic Cell Death in Neuroblastoma SH-SY5Y Cells",
        "Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease",
        "Advances in brain targeted drug delivery: Nanoparticulate systems",
        "\u03b1-Mangostin Mediated Pharmacological Modulation of Hepatic Carbohydrate Metabolism in Diabetes Induced Wistar Rat",
        "Nanostructured lipid carriers for site-specific drug delivery",
        "Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat",
        "Protein measurement with the Folin phenol reagent",
        "Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments",
        "Motor Control Abnormalities in Parkinson's Disease",
        "The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase",
        "Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease",
        "Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease",
        "Alpha-mangostin attenuates brain inflammation induced by peripheral lipopolysaccharide administration in C57BL/6J mice",
        "Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson\u2019s disease",
        "Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity",
        "N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins",
        "Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease",
        "The evaluation of the changes in enzymatic antioxidant reserves and lipid peroxidation in chosen parts of the brain in an animal model of Parkinson disease",
        "Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency",
        "Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats",
        "Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat",
        "The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings",
        "Nanoparticle Drug Delivery Systems for \u03b1-Mangostin",
        "Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression",
        "Rotenone reduces Mg2+-dependent block of NMDA currents in substantia nigra dopamine neurons",
        "Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance",
        "Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease",
        "Nanocarrier-mediated delivery of \u03b1-mangostin for non-surgical castration of male animals",
        "Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease",
        "Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson\u2019s Disease Models"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60021944",
            "affilname": "Kasetsart University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Zoology",
        "Faculty of Science, Kasetsart University",
        "Kasetsart University",
        "Faculty of Science"
    ]
}